Parkside Financial Bank & Trust’s Xylem XYL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $360K | Sell |
3,011
-125
| -4% | -$16.4K | 0.03% | 315 |
|
|
2025
Q4 | $427K | Buy |
3,136
+57
| +2% | +$8.2K | 0.03% | 288 |
|
|
2025
Q3 | $454K | Sell |
3,079
-41
| -1% | -$5.69K | 0.04% | 270 |
|
|
2025
Q2 | $404K | Buy |
3,120
+31
| +1% | +$3.75K | 0.04% | 283 |
|
|
2025
Q1 | $369K | Buy |
3,089
+4
| +0.1% | +$496 | 0.05% | 265 |
|
|
2024
Q4 | $358K | Buy |
3,085
+7
| +0.2% | +$885 | 0.05% | 258 |
|
|
2024
Q3 | $416K | Sell |
3,078
-91
| -3% | -$12.2K | 0.06% | 229 |
|
|
2024
Q2 | $430K | Buy |
3,169
+95
| +3% | +$12.9K | 0.07% | 208 |
|
|
2024
Q1 | $397K | Buy |
3,074
+75
| +3% | +$9.06K | 0.06% | 223 |
|
|
2023
Q4 | $343K | Buy |
2,999
+2,068
| +222% | +$206K | 0.06% | 234 |
|
|
2023
Q3 | $84.8K | Sell |
931
-33
| -3% | -$3.4K | 0.02% | 462 |
|
|
2023
Q2 | $109K | Buy |
964
+298
| +45% | +$31.5K | 0.03% | 390 |
|
|
2023
Q1 | $69.7K | Sell |
666
-9
| -1% | -$940 | 0.02% | 482 |
|
|
2022
Q4 | $74.6K | Sell |
675
-59
| -8% | -$6.18K | 0.02% | 451 |
|
|
2022
Q3 | $64K | Sell |
734
-30
| -4% | -$2.73K | 0.02% | 451 |
|
|
2022
Q2 | $59K | Buy |
764
+126
| +20% | +$10.4K | 0.02% | 476 |
|
|
2022
Q1 | $54K | Buy |
638
+455
| +249% | +$43.6K | 0.01% | 527 |
|
|
2021
Q4 | $22K | Sell |
183
-29
| -14% | -$3.6K | 0.01% | 788 |
|
|
2021
Q3 | $26K | Buy |
212
+32
| +18% | +$4.12K | 0.01% | 708 |
|
|
2021
Q2 | $22K | Sell |
180
-1
| -0.6% | -$114 | 0.01% | 759 |
|
|
2021
Q1 | $19K | Buy |
181
+19
| +12% | +$1.93K | 0.01% | 783 |
|
|
2020
Q4 | $16K | Buy |
162
+4
| +3% | +$376 | 0.01% | 784 |
|
|
2020
Q3 | $13K | Sell |
158
-7
| -4% | -$545 | ﹤0.01% | 767 |
|
|
2020
Q2 | $11K | Buy |
165
+38
| +30% | +$2.51K | ﹤0.01% | 800 |
|
|
2020
Q1 | $8K | Sell |
127
-2
| -2% | -$158 | ﹤0.01% | 785 |
|
|
2019
Q4 | $10K | Buy |
129
+14
| +12% | +$1.09K | ﹤0.01% | 809 |
|
|
2019
Q3 | $9K | Hold |
115
| – | – | ﹤0.01% | 815 |
|
|
2019
Q2 | $10K | Buy |
115
+5
| +5% | +$398 | ﹤0.01% | 811 |
|
|
2019
Q1 | $9K | Hold |
110
| – | – | ﹤0.01% | 823 |
|
|
2018
Q4 | $7K | Buy |
110
+80
| +267% | +$5.54K | ﹤0.01% | 844 |
|
|
2018
Q3 | $2K | Buy |
30
+3
| +11% | +$224 | ﹤0.01% | 1150 |
|
|
2018
Q2 | $2K | Buy |
27
+3
| +13% | +$218 | ﹤0.01% | 1123 |
|
|
2018
Q1 | $2K | Hold |
24
| – | – | ﹤0.01% | 1064 |
|
|
2017
Q4 | $2K | Hold |
24
| – | – | ﹤0.01% | 1026 |
|
|
2017
Q3 | $2K | Hold |
24
| – | – | ﹤0.01% | 1021 |
|
|
2017
Q2 | $1K | Hold |
24
| – | – | ﹤0.01% | 1285 |
|
|
2017
Q1 | $1K | Hold |
24
| – | – | ﹤0.01% | 1237 |
|
|
2016
Q4 | $1K | Hold |
24
| – | – | ﹤0.01% | 1239 |
|
|
2016
Q3 | $1K | Hold |
24
| – | – | ﹤0.01% | 1040 |
|
|
2016
Q2 | $1K | Hold |
24
| – | – | ﹤0.01% | 1024 |
|
|
2016
Q1 | $1K | Sell |
24
-26
| -52% | -$957 | ﹤0.01% | 1008 |
|
|
2015
Q4 | $2K | Buy |
50
+26
| +108% | +$940 | ﹤0.01% | 939 |
|
|
2015
Q3 | $1K | Buy |
+24
| New | +$807 | ﹤0.01% | 1029 |
|
Other funds holding XYL
VCM
VPM
Parkside Financial Bank & Trust's XYL Position: Q1 2026 in Review
Parkside Financial Bank & Trust reduced its Xylem (XYL) stake by 4% in Q1 2026, selling an estimated $16.4K and leaving 3,011 shares worth $360K. The position accounts for 0.03% of the portfolio, ranked #315.
Parkside Financial Bank & Trust first reported a position in XYL in Q3 2015 and has held it in 43 quarters since. The position peaked at $454K in Q3 2025. 1,108 funds tracked by Wall St. Rank hold XYL as of Q1 2026.
- Parkside Financial Bank & Trust held 3,011 shares of Xylem worth $360K as of Q1 2026.
- Parkside Financial Bank & Trust sold 125 Xylem shares in Q1 2026, an estimated $16.4K.
- Xylem made up 0.03% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #315 holding.
- Parkside Financial Bank & Trust first reported a position in Xylem in Q3 2015 and has held it in 43 quarters since.
- Parkside Financial Bank & Trust's Xylem position peaked at $454K in Q3 2025.
- 1,108 funds tracked by Wall St. Rank held Xylem as of Q1 2026.
Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.